• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Diversity of Omicron sublineages and clinical characteristics in hospitalized patients in the southernmost state of Brazil

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2024 Feb 13;24(1):193.
doi: 10.1186/s12879-024-09089-3. Diversity of Omicron sublineages and clinical characteristics in hospitalized patients in the southernmost state of Brazil

Jaqueline Rhoden[SUP] 1 2 [/SUP], Andressa Taíz Hoffmann[SUP] 3 [/SUP], Janaína Franciele Stein[SUP] 4 [/SUP], Mariana Soares da Silva[SUP] 4 [/SUP], Juliana Schons Gularte[SUP] 4 [/SUP], Micheli Filippi[SUP] 4 [/SUP], Meriane Demoliner[SUP] 4 [/SUP], Viviane Girardi[SUP] 4 [/SUP], Fernando Rosado Spilki[SUP] 4 [/SUP], Juliane Deise Fleck[SUP] 4 [/SUP], Caroline Rigotto[SUP] 4 [/SUP]



Affiliations
Abstract

Background: Omicron has become the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since first reported in November 2021. From the initially detected Wuhan lineage, sublineages BA.2, BA.4, BA.5, BQ, XAG, and XBB have emerged over time and are dominant in many countries. Therefore, the aim is to evaluate which variants are circulating and the clinical characteristics of inpatients infected with the Omicron variant.
Methods: This retrospective cohort study selected hospitalized patients admitted with respiratory symptoms to a hospital in the state of Rio Grande do Sul, Brazil, between June and July 2022. SARS-CoV-2 results were analyzed together with clinical outcomes and vaccination status. A viral genome library was prepared and forwarded to the Illumina MiSeq Platform for sequencing.
Results: In total, 37 genomes were sequenced. Concerning the Omicron sublineages, our study detected: BA.1 (21 K), BA.2 (21 L), BA.4 (22A), BA.5 (22B), BA.2.12.1 (22C), BQ.1 (22E), XBB (22F), and XAG recombinant. Omicron BA.5 (30%), BA.2 (19%), and BQ.1 (19%) were the most frequent sublineages, respectively. In total, 38% of patients present hypertension, and the most common symptoms were coughing (62%). Analyzing the COVID-19 vaccination, 30% of patients were fully vaccinated, 49% had a partial vaccination status, and 21% were unvaccinated (no dose).
Conclusions: BA.5 was the most prevalent sublineage in our study and surpassed the predominance of BA.2, as reported by the national genomic surveillance program. BQ.1 was diagnosed earlier in this study than it was officially reported in the state. Current data have demonstrated that the Omicron variant causes less severe infections, with the high rate of transmissibility and mutational landscape causing the rapid emergence of new sublineages.

Keywords: NGS; SARS-CoV-2; Sequencing; Vaccination.

 
Back
Top Bottom